CGD Contributions to Enhancing the “Value for Money” of HIV/AIDS Financing


This case study is one of five produced as part of an external assessment undertaken between 2020-2022 to examine how CGD contributed to influence and impact in some of its areas of work. The case studies detail five notable initiatives from CGD’s first 20 years. This external assessment was led by Benjamin Soskis of the Urban Institute’s Center on Nonprofits and Philanthropy and overseen by Amanda Glassman with coordination and support from Brin Datema in consultation with CGD president Masood Ahmed. Each case study was researched and authored by independent consultants to CGD. The full collection of case studies and related materials is available here.

A core element of CGD’s global health policy program is analyzing the value for money (VfM) of global health investments, or the efficiency, effectiveness, and impact of global health funding agencies and their performance incentives. A significant share of CGD’s work on VfM in global health has focused specifically on HIV/AIDS financing. 

This case study examines the extent to which CGD’s work may have impacted the adoption of a VfM agenda at HIV donor agencies and analyzes the evidentiary basis for claims regarding the specific mechanisms by which it did so. In particular, it focuses on the work carried out through CGD’s HIV/AIDS Monitor, Value for Money Working Group, and Next Generation Financing Models in Global Health Working Group, and the impact of those initiatives on the Global Fund to Fight AIDS, Tuberculosis and Malaria (the Global Fund) and the President’s Emergency Plan for AIDS Relief (PEPFAR).


Rights & Permissions

You may use and disseminate CGD’s publications under these conditions.